Market Place
Sourcing Support
ORIC® Pharmaceuticals to Participate in Investor Conferences
04 Nov 2024 //
GLOBENEWSWIRE
ORIC® Pharma Reports Inducement Grants under Nasdaq LR 5635(c)(4)
01 Nov 2024 //
GLOBENEWSWIRE
ORIC® Pharmaceuticals Presents Data on ORIC-114 at EORTC
23 Oct 2024 //
GLOBENEWSWIRE
ORIC Pharma Announces Presentation At EORTC On Molecular Target
09 Oct 2024 //
GLOBENEWSWIRE
ORIC Reports Inducement Grants under Nasdaq LR 5635(c)(4)
04 Oct 2024 //
GLOBENEWSWIRE
OpenBench and ORIC Pharmaceuticals Launch Success-Driven Discovery Collaboration
17 Sep 2024 //
PR NEWSWIRE
ORIC Pharmaceuticals Reports Inducement Grants Under Nasdaq Rule
06 Sep 2024 //
GLOBENEWSWIRE
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
26 Aug 2024 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Reports Q2 2024 Results And Operational Updates
12 Aug 2024 //
GLOBENEWSWIRE
ORIC Pharma Appoints Keith Lui As SVP Of Commercial And Medical Affairs
05 Aug 2024 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule
02 Aug 2024 //
GLOBENEWSWIRE
ORIC Pharma Announces Collaborations For ORIC-944 Prostate Cancer Trial
16 Jul 2024 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule
05 Jul 2024 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Reports Inducement Grants
07 Jun 2024 //
GLOBENEWSWIRE
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
29 May 2024 //
GLOBENEWSWIRE
ORIC Reports Q1 2024 Results, Operational Updates
06 May 2024 //
GLOBENEWSWIRE
ORIC Reports Nasdaq Listing Rule Inducement Grants
03 May 2024 //
GLOBENEWSWIRE
ORIC Doses First NSCLC Patients In ORIC-114 Phase 1b Expansion
15 Apr 2024 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Presents Data on Two Programs at the 2024 AACR
08 Apr 2024 //
GLOBENEWSWIRE
ORIC Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
05 Apr 2024 //
GLOBENEWSWIRE
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
04 Apr 2024 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
11 Mar 2024 //
GLOBENEWSWIRE
ORIC Pharma to Present at the Leerink Partners Global Biopharma Conference
06 Mar 2024 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Announces Multiple Presentations
05 Mar 2024 //
GLOBENEWSWIRE
ORIC Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 Mar 2024 //
GLOBENEWSWIRE
ORIC Pharma to Participate in the Citi 2024 Virtual Oncology Leadership Summit
14 Feb 2024 //
GLOBENEWSWIRE
ORIC Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02 Feb 2024 //
GLOBENEWSWIRE
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
31 Jan 2024 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
22 Jan 2024 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Provides Initial Phase 1b Data for ORIC-944
08 Jan 2024 //
GLOBENEWSWIRE
ORIC Pharma to Present at the 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 //
GLOBENEWSWIRE
Initial Phase 1 Data for ORIC-533 in Multiple Myeloma Shows Clinical Activity
11 Dec 2023 //
GLOBENEWSWIRE
ORIC Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 Dec 2023 //
GLOBENEWSWIRE
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
09 Nov 2023 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Reports Third Quarter 2023 Financial Results
06 Nov 2023 //
GLOBENEWSWIRE
ORIC Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 Nov 2023 //
GLOBENEWSWIRE
ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC-533
02 Nov 2023 //
GLOBENEWSWIRE
Initial Phase 1 Dose Escalation Data of ORIC-114 in Patients with EGFR
21 Oct 2023 //
GLOBENEWSWIRE
ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC 114
17 Oct 2023 //
GLOBENEWSWIRE
ORIC Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06 Oct 2023 //
GLOBENEWSWIRE
ORIC Pharma to Participate in the 2023 Cantor Global Healthcare Conference
20 Sep 2023 //
GLOBENEWSWIRE
ORIC Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 Sep 2023 //
GLOBENEWSWIRE
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
30 Aug 2023 //
GLOBENEWSWIRE
ORIC Reports Second Quarter 2023 Financial Results and Operational Updates
10 Aug 2023 //
GLOBENEWSWIRE
ORIC Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
04 Aug 2023 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing
26 Jun 2023 //
GLOBENEWSWIRE
Why Shares of Oric Pharmaceuticals Jumped Monday
26 Jun 2023 //
PRESS RELEASE
ORIC Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
02 Jun 2023 //
GLOBENEWSWIRE
ORIC Pharmaceuticals to Participate in the Jefferies Healthcare Conference
31 May 2023 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Reports 1Q 2023 FYR and Operational Updates
08 May 2023 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule
05 May 2023 //
GLOBENEWSWIRE
ORIC Pharmaceuticals to Participate in the H.C. Wainwright BioConnect Conference
25 Apr 2023 //
GLOBENEWSWIRE
ORIC Pharma Presents Promising Preclinical Data on Two Programs at the 202AASR
18 Apr 2023 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
16 Mar 2023 //
GLOBENEWSWIRE
ORIC Pharmaceuticals Announces Multiple Presentations at AACR Annual Meeting
14 Mar 2023 //
GLOBENEWSWIRE
ORIC Pharma to Participate in the Oppenheimer 33rd Annual Healthcare Conference
06 Mar 2023 //
GLOBENEWSWIRE
ORIC Pharmas Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 Feb 2023 //
GLOBENEWSWIRE
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
01 Feb 2023 //
GLOBENEWSWIRE
ORIC Pharma Provides Corporate Update and Highlights Key Upcoming Milestones
09 Jan 2023 //
GLOBENEWSWIRE
ORIC Pharmaceuticals to Present at the 41st Annual J.P. Morgan Conference
03 Jan 2023 //
GLOBENEWSWIRE
